These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 3071922

  • 1. [Calcium antagonists: anti-atherosclerotic effect by modification of the prostaglandin system].
    Weiss K.
    Wien Klin Wochenschr; 1988 Nov 04; 100(21):718-20. PubMed ID: 3071922
    [Abstract] [Full Text] [Related]

  • 2. Influence of calcium antagonists on platelet function and vascular prostacyclin production.
    Pirich C, Schmid P, Fitscha P, Wytek R, O'Grady J, Sinzinger H.
    Blood Press Suppl; 1994 Nov 04; 1():75-80. PubMed ID: 8205307
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
    Han P, Boatwright C, Ardlie NG.
    Thromb Haemost; 1983 Aug 30; 50(2):513-7. PubMed ID: 6314581
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential actions of naftopidil, doxazosin and nifedipine on platelet thromboxane generation and platelet-derived growth factor efflux in vitro.
    Alarayyed NA, Prichard BN, Betteridge DJ, Smith CC.
    Platelets; 2002 Aug 30; 13(5-6):267-71. PubMed ID: 12189011
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury.
    Simpson PJ, Smith CB, Rosenthal G, Lucchesi BR.
    J Pharmacol Exp Ther; 1986 Aug 30; 238(2):497-501. PubMed ID: 3735129
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serotonin and platelet activation during treatment with isradipine.
    Fetkovska N, Sebekova K, Fedelesova V, Dzurik R.
    J Cardiovasc Pharmacol; 1991 Aug 30; 18 Suppl 3():S31-3. PubMed ID: 1720482
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A study of platelet aggregation, thromboxane A2 and prostacyclin in central aortic and coronary sinus blood in ischemic heart disease.
    Narain VS, Bhargava B, Chandra N, Puri VK, Hasan M.
    Indian Heart J; 1994 Aug 30; 46(4):149-52. PubMed ID: 7875701
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effects of diltiazem on platelet activation caused by ionophore A23187 plus ADP or epinephrine in subthreshold concentrations.
    Mehta P, Mehta J, Ostrowski N, Brigmon L.
    J Lab Clin Med; 1983 Sep 30; 102(3):332-9. PubMed ID: 6411841
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.